Effect of coadministration of corticosteroids on the development of contact sensitization

Journal of the American Academy of Dermatology

Volumn 35, Issue 1, 1996, Pages 27-31

  Amkraut, Alfred A ^a   Jordan, William P ^b   Taskovich, Lina ^a   Yuen, James ^a  

^a ALZA CORPORATION   (United States)

^b Dermatology Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; DEXCHLORPHENIRAMINE; HYDROCORTISONE;

ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTACT DERMATITIS; CONTACT SENSITIVITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RASH; STEROID THERAPY; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 15844425228     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90491-0     Document Type: Article

References (27)

1. Physicians' desk reference. 49th ed. Montvale, NJ: Medical Economics Data Production, 1995:637-8.
2. Belsito DV, Flotte TJ, Lim HW, et al. Effect of glucocorticosteroids on epidermal Langerhans cells. J Exp Med 1982;155:291-302.
3. Berman B, France DS, Martinelli GP, et al. Modulation of expression of epidermal Langerhans cell properties following in situ exposure to glucocorticosteroids. J Invest Dermatol 1983;80:168-71.
4. Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 1980;124:445-53.
5. Burrows WM, Stoughton RB. Inhibition of induction of human contact sensitization by topical glucocorticosteroids. Arch Dermatol 1976;112:175-8.
6. Jordan WP Jr, King SE. Delayed hypersensitivity in females: the development of allergic contact dermatitis in females during the comparison of two predictive patch tests. Contact Dermatitis 1977;3:19-26.
7. Jordan WP. 24-, 48-, and 48/48-hour patch tests. Contact Dermatitis 1980;6:151-2.
8. Freger S. Manual of contact dermatitis. Copenhagen: Munksgaard, 1981:71-80.
9. Rebs JL, Friedmann PS, Matthews JNS. Sex differences in susceptibility to development of contact hypersensitivity to dinitrochlorobenzene (DNCB). Br J Dermatol 1989;120: 371-4.
10. Magnusson B, Kligman AM. Allergic contact dermatitis in the guinea pig: identification of contact allergies. Spring-field, IL: Charles C Thomas, 1986:60-1.
11. Rugstad HE. Antiinflammatory and immunoregulatory effects of glucocorticoids: mode of action. Scand J Rheumatol 1988;76(suppl):257-64.
12. Knight SC. Dendritic cells in contact sensitivity. Res Immunol 1989;130:907-10.
13. Kripke ML, Munn CG, Jeevan A, et al. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990;145: 2833-8.
14. Snyder DS, Unanue ER. Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol 1982;129:1803-5.
15. Becker D, Knop J. Mechanism in allergic contact dermatitis. Exp Dermatol 1993;2:63-9.
16. Katz S. The skin as an immunological organ: allergic contact dermatitis as a paradigm. J Dermatol 1993;20:593-603.
17. Ashworth J, Kahan MC, Breathnach SM. Flow cytometrically-sorted residual HLA-DR + T6 + Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity. J Invest Dermatol 1989;92: 258-62.
18. Furue M, Katz SI. Direct effects of glucocorticosteroids on epidermal Langerhans cells. J Invest Dermatol 1989;92: 342-7.
19. Cumberbatch M, Kimber I. Dermal tumor necrosis factor-á induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology 1992;75:257-63.
20. Beutler B, Krochin N, Milsark IW, et al. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986;232:977-9.
21. Macher E, Chase MW. Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1969; 129:103-21.
22. Hammerling GJ, Schonrich G, Ferber I, et al. Peripheral tolerance as a multi-step mechanism. Immunol Rev 1993; 133:93-103.
23. Ramsdell F, Fowlkes BJ. Maintenance of in vivo tolerance by persistence of antigen. Science 1992;257:1130-4.
24. Gruner S, Diezel W, Strunk D, et al. Inhibition of Langerhans cell ATPase and contact sensitization by lanthanides: role of T-suppressor cells. J Invest Dermatol 1991;97:478-82.
25. Rheins LA, Barnes L, Amornsiripanitch S, et al. Suppression of the cutaneous immune response following topical application of the prostaglandin PGE2. Cell Immunol 1987;106:233-42.
26. Sharpe RJ, Chandrasekar A, Arndt KA, et al. Inhibition of cutaneous contact hypersensitivity in the mouse with systemic or topical spiperone: topical application of spiperone produces local immunosuppression without inducing systemic neuroleptic effects. J Invest Dermatol 1992;99:594-600.
27. Lubach D, Bensmann A, Bornemann U. Steroid-induced dermal atrophy. Dermatologica 1989;179:67-72.